Orient Pharma Co. Ltd.

Orient Pharma Co., Ltd. develops new drugs in Taiwan and internationally. Its product portfolio includes cardiovascular drugs such as Pitator and Tonvasca for lipid suppression, and Zulitor, a lipid-lowering drug, as well as psychotropic drugs including Trokendi XR extended, Methydur, and a powder and solvent for prolonged-release suspension for injection. The company was founded in 2008 and is based in Taipei, Taiwan.